Neuland Labs Q2FY27: Net profit falls 47% YoY, margin dips to 21.7%
Net profit fell 46.7% YoY to ₹51.6 crore in Q2FY27. EBITDA margin contracted to 21.7% from 30.25% in Q2FY26. Peptide PPQ revenues expected within 6-9 months; commercial follow-on in next 6-9 months. Board approved ₹47.1 crore capex for land in Telangana; 134 acres acquired in Kakinada. Operating cash flow surged to ₹361.6 crore in H1FY27 due to receivable reduction.
